The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies.

Saved in:
Bibliographic Details
Title: The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies.
Authors: Duan Wang1, Linhao Li1, Hui Yang1, Ferguson, Stephen S.2, Baer, Maria R.3, Gartenhaus, Ronald B.3, Hongbing Wang1 hwang@rx.umaryland.edu
Source: Blood. 1/10/2013, Vol. 121 Issue 2, p329-338. 10p.
Database: Academic Search Ultimate
Description
ISSN:00064971
DOI:10.1182/blood-2012-06-436691